CN113430188A - 一种新型壳聚糖酶及其制备方法 - Google Patents
一种新型壳聚糖酶及其制备方法 Download PDFInfo
- Publication number
- CN113430188A CN113430188A CN202110960970.6A CN202110960970A CN113430188A CN 113430188 A CN113430188 A CN 113430188A CN 202110960970 A CN202110960970 A CN 202110960970A CN 113430188 A CN113430188 A CN 113430188A
- Authority
- CN
- China
- Prior art keywords
- chitosanase
- csna
- chitosan
- gly
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010089807 chitosanase Proteins 0.000 title claims abstract description 80
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 108090000790 Enzymes Proteins 0.000 claims abstract description 45
- 102000004190 Enzymes Human genes 0.000 claims abstract description 39
- 101150118197 CSN1S1 gene Proteins 0.000 claims abstract description 31
- 229920001661 Chitosan Polymers 0.000 claims abstract description 29
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 15
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000013612 plasmid Substances 0.000 claims description 10
- 239000013598 vector Substances 0.000 claims description 7
- 230000000593 degrading effect Effects 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000001131 transforming effect Effects 0.000 claims description 5
- 230000002441 reversible effect Effects 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 108020004705 Codon Proteins 0.000 abstract description 6
- 241000187432 Streptomyces coelicolor Species 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000002538 fungal effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 5
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 5
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 5
- 229960002442 glucosamine Drugs 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000187747 Streptomyces Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- IJHUZMGJRGNXIW-CIUDSAMLSA-N Asp-Glu-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IJHUZMGJRGNXIW-CIUDSAMLSA-N 0.000 description 3
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 108010093581 aspartyl-proline Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000007222 ypd medium Substances 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- NKJBKNVQHBZUIX-ACZMJKKPSA-N Ala-Gln-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKJBKNVQHBZUIX-ACZMJKKPSA-N 0.000 description 2
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 2
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 2
- PVQLRJRPUTXFFX-CIUDSAMLSA-N Ala-Met-Gln Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O PVQLRJRPUTXFFX-CIUDSAMLSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 2
- ANAHQDPQQBDOBM-UHFFFAOYSA-N Arg-Val-Tyr Natural products CC(C)C(NC(=O)C(N)CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O ANAHQDPQQBDOBM-UHFFFAOYSA-N 0.000 description 2
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 2
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- OXEMJGCAJFFREE-FXQIFTODSA-N Glu-Gln-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O OXEMJGCAJFFREE-FXQIFTODSA-N 0.000 description 2
- 108010050006 Gly-Asp-Gly-Arg Proteins 0.000 description 2
- ZRZILYKEJBMFHY-BQBZGAKWSA-N Gly-Asp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN ZRZILYKEJBMFHY-BQBZGAKWSA-N 0.000 description 2
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 2
- QVDGHDFFYHKJPN-QWRGUYRKSA-N Gly-Phe-Cys Chemical compound NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(O)=O QVDGHDFFYHKJPN-QWRGUYRKSA-N 0.000 description 2
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 2
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 2
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 2
- MSSJHBAKDDIRMJ-SRVKXCTJSA-N Met-Lys-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O MSSJHBAKDDIRMJ-SRVKXCTJSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 2
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 2
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 2
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 2
- 108010025216 RVF peptide Proteins 0.000 description 2
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 2
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 2
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 2
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 108010045023 alanyl-prolyl-tyrosine Proteins 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 108010070783 alanyltyrosine Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 2
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 2
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 2
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 1
- CXQODNIBUNQWAS-CIUDSAMLSA-N Ala-Gln-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CXQODNIBUNQWAS-CIUDSAMLSA-N 0.000 description 1
- ZDYNWWQXFRUOEO-XDTLVQLUSA-N Ala-Gln-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDYNWWQXFRUOEO-XDTLVQLUSA-N 0.000 description 1
- NJPMYXWVWQWCSR-ACZMJKKPSA-N Ala-Glu-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NJPMYXWVWQWCSR-ACZMJKKPSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- DRARURMRLANNLS-GUBZILKMSA-N Ala-Met-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O DRARURMRLANNLS-GUBZILKMSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- CQJHFKKGZXKZBC-BPNCWPANSA-N Ala-Pro-Tyr Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CQJHFKKGZXKZBC-BPNCWPANSA-N 0.000 description 1
- VYMJAWXRWHJIMS-LKTVYLICSA-N Ala-Tyr-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VYMJAWXRWHJIMS-LKTVYLICSA-N 0.000 description 1
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 1
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 1
- QTAIIXQCOPUNBQ-QXEWZRGKSA-N Arg-Val-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QTAIIXQCOPUNBQ-QXEWZRGKSA-N 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- BXUHCIXDSWRSBS-CIUDSAMLSA-N Asn-Leu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BXUHCIXDSWRSBS-CIUDSAMLSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 1
- CXBOKJPLEYUPGB-FXQIFTODSA-N Asp-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N CXBOKJPLEYUPGB-FXQIFTODSA-N 0.000 description 1
- BLQBMRNMBAYREH-UWJYBYFXSA-N Asp-Ala-Tyr Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O BLQBMRNMBAYREH-UWJYBYFXSA-N 0.000 description 1
- SEMWSADZTMJELF-BYULHYEWSA-N Asp-Ile-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O SEMWSADZTMJELF-BYULHYEWSA-N 0.000 description 1
- HJZLUGQGJWXJCJ-CIUDSAMLSA-N Asp-Pro-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJZLUGQGJWXJCJ-CIUDSAMLSA-N 0.000 description 1
- IHZFGJLKDYINPV-XIRDDKMYSA-N Asp-Trp-His Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(O)=O)N)C(O)=O)C1=CN=CN1 IHZFGJLKDYINPV-XIRDDKMYSA-N 0.000 description 1
- FIRWLDUOFOULCA-XIRDDKMYSA-N Asp-Trp-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N FIRWLDUOFOULCA-XIRDDKMYSA-N 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- LJEPDHWNQXPXMM-NHCYSSNCSA-N Gln-Arg-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O LJEPDHWNQXPXMM-NHCYSSNCSA-N 0.000 description 1
- JNVGVECJCOZHCN-DRZSPHRISA-N Gln-Phe-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O JNVGVECJCOZHCN-DRZSPHRISA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 1
- DCBSZJJHOTXMHY-DCAQKATOSA-N Glu-Pro-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DCBSZJJHOTXMHY-DCAQKATOSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 1
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 1
- DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- AKEDPWJFQULLPE-IUCAKERBSA-N His-Glu-Gly Chemical compound N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O AKEDPWJFQULLPE-IUCAKERBSA-N 0.000 description 1
- NDKSHNQINMRKHT-PEXQALLHSA-N His-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N NDKSHNQINMRKHT-PEXQALLHSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 1
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 1
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- JCFYLFOCALSNLQ-GUBZILKMSA-N Lys-Ala-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JCFYLFOCALSNLQ-GUBZILKMSA-N 0.000 description 1
- LLSUNJYOSCOOEB-GUBZILKMSA-N Lys-Glu-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O LLSUNJYOSCOOEB-GUBZILKMSA-N 0.000 description 1
- WXJXYMFUTRXRGO-UWVGGRQHSA-N Met-His-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 WXJXYMFUTRXRGO-UWVGGRQHSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 1
- LZDIENNKWVXJMX-JYJNAYRXSA-N Phe-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CC=CC=C1 LZDIENNKWVXJMX-JYJNAYRXSA-N 0.000 description 1
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 1
- XQSREVQDGCPFRJ-STQMWFEESA-N Pro-Gly-Phe Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XQSREVQDGCPFRJ-STQMWFEESA-N 0.000 description 1
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 1
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 1
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 1
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 1
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- QNMIVTOQXUSGLN-SZMVWBNQSA-N Trp-Arg-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QNMIVTOQXUSGLN-SZMVWBNQSA-N 0.000 description 1
- QEJHHFFFCUDPDV-WDSOQIARSA-N Trp-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N QEJHHFFFCUDPDV-WDSOQIARSA-N 0.000 description 1
- DYEGCOJHFNJBKB-UFYCRDLUSA-N Tyr-Arg-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 DYEGCOJHFNJBKB-UFYCRDLUSA-N 0.000 description 1
- AKLNEFNQWLHIGY-QWRGUYRKSA-N Tyr-Gly-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)O AKLNEFNQWLHIGY-QWRGUYRKSA-N 0.000 description 1
- GIOBXJSONRQHKQ-RYUDHWBXSA-N Tyr-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O GIOBXJSONRQHKQ-RYUDHWBXSA-N 0.000 description 1
- ILTXFANLDMJWPR-SIUGBPQLSA-N Tyr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N ILTXFANLDMJWPR-SIUGBPQLSA-N 0.000 description 1
- YKCXQOBTISTQJD-BZSNNMDCSA-N Tyr-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N YKCXQOBTISTQJD-BZSNNMDCSA-N 0.000 description 1
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 1
- XUIOBCQESNDTDE-FQPOAREZSA-N Tyr-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XUIOBCQESNDTDE-FQPOAREZSA-N 0.000 description 1
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- IRAUYEAFPFPVND-UVBJJODRSA-N Val-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 IRAUYEAFPFPVND-UVBJJODRSA-N 0.000 description 1
- GUIYPEKUEMQBIK-JSGCOSHPSA-N Val-Tyr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O GUIYPEKUEMQBIK-JSGCOSHPSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 108010002480 endodeoxyribonuclease SacI Proteins 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2442—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01014—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开一种新型壳聚糖酶及其制备方法,属于基因工程技术领域。本发明壳聚糖酶基因CsnA的核苷酸序列如SEQID NO:1所示,其是通过对来源于天蓝色链霉菌的壳聚糖酶的序列根据毕赤酵母密码子的偏好性进行综合优化得到。本发明壳聚糖酶CsnA的氨基酸序列如SEQ ID NO:2所示,是一种真菌壳聚糖酶,不仅丰富了壳聚糖酶的种类和来源途径,且自身具有较高的酶活性,在较宽的温度和pH范围内均表现出良好的稳定性,具有良好的应用前景和产业价值。
Description
技术领域
本发明属于基因工程技术领域,特别涉及一种新型壳聚糖酶基因、新型壳聚糖酶及其制备方法。
背景技术
壳聚糖酶是一种生物酶,作为专一性的水解酶,由于水解壳聚糖是生产不同分子量的壳聚糖产物的关键酶,其可特异性地使糖苷键断裂,作为一种极为重要的壳聚糖的制备方法,其生产形成分子量较低的壳寡糖。壳寡糖具有提高免疫能力、抑制肿瘤细胞生长、降低胆固醇和抗氧化等方面具有较强活性,在功能食品、医药、化妆品及农作物生物制剂领域具有独特而重要的应用。
壳聚糖酶广泛地存在于多种生物中,在细菌、真菌、病毒以及植物中均发现了壳聚糖酶。目前壳聚糖酶的研究主要集中在细菌壳聚糖酶,主要分为链霉菌壳聚糖酶和芽孢杆菌壳聚糖酶。其中,芽孢杆菌壳聚糖酶能够有效分解壳聚糖并且水解产物具有很好的生物活性。但细菌壳聚糖酶价格昂贵、活力较低、温度范围较窄,且稳定性较差,严重限制了壳聚糖酶的应用前景。
发明内容
本发明针对现有技术的不足,提供一种新型壳聚糖酶及其制备方法,解决了目前壳聚糖酶来源途径、活力低、温度范围窄、pH稳定性差的问题。本发明通过天蓝色链霉菌壳聚糖酶的序列根据毕赤酵母密码子的偏好性进行综合优化得到,丰富了壳聚糖酶的种类和来源途径,且其自身具有较高的酶活性,在较宽的温度和pH范围内均表现出良好的稳定性。为实现本发明目的所使用的技术方案为:
一种新型壳聚糖酶CsnA,其核苷酸序列如SEQ ID NO:1所示。
优选地,其氨基酸序列如SEQ ID NO:2所示。
本发明还提供一种新型壳聚糖酶CsnA在降解壳聚糖/制备壳聚糖中的应用;在制备降解壳聚糖/制备壳聚糖的酶制剂的应用。
另外地,本发明提供一种重组表达载体,包括以上所述新型壳聚糖酶CsnA。
优选地,一种新型壳聚糖酶CsnA的制备方法如下,提供壳聚糖酶CsnA基因、构建载体质粒和毕赤酵母转化;
对所述载体质粒进行转化;
对所述壳聚糖酶CsnA基因进行扩增;
其中,所述壳聚糖酶CsnA的核苷酸序列如SEQ ID NO:1所示。
优选地,将所述壳聚糖酶CsnA基因进行扩增的步骤中,用于扩增的引物包括正向引物和反向引物,所述正向引物的核苷酸序列如SEQ ID NO:3所示,所述反向引物的核苷酸序列如SEQ ID NO:4所示。
优选地,所述载体为毕赤酵母表达载体。
优选地,所述表达菌株为毕赤酵母表达菌株。
本发明提供一种酶制剂,包含有以上所述的新型壳聚糖酶CsnA。
优选地,如以上所述酶制剂在降解壳聚糖/制备壳寡糖中的应用。
本发明的有益效果是:
本申请的壳聚糖酶CsnA不仅丰富了壳聚糖酶的种类和来源途径,由于该壳聚糖酶CsnA在较宽的温度和pH范围内均表现出良好的稳定性,因此用于水解壳聚糖时,可使水解反应高效、稳定地进行,有利于提升水解产物壳寡糖的产量。通过实验发现,本发明提供的壳聚糖酶CsnA水解壳聚糖,所得水解产物主要为壳二糖和壳三糖,该产物作为壳寡糖的主要活性成分,且其自身具有较高的酶活性,具有良好的应用前景和产业价值。
附图说明
图1是pPIC9K-CsnA Mut+His+表型筛选结果图。
图2是壳聚糖酶基因组PCR验证结果图。
图3是pPIC9K-CsnA多拷贝筛选结果图。
图4是壳聚糖酶SDS-PAGE检测结果图。
图5是壳聚糖酶酶活测定结果图。
图6是氨基葡萄糖标准曲线图。
图7是壳聚糖酶的最适反应温度(A)和温度稳定性(B)结果图。
图8是壳聚糖酶的最适作用pH(A)和酸碱稳定性(B)结果图。
图9是酶解产物1H NMR(a) 及13C NMR(b) 分析结果图。
图10是壳聚糖酶降解壳聚糖2h的薄层层析结果图。
具体实施方式
下面结合实施例对本发明方案做进一步详细描述,下述说明仅是为了解释本发明,并不对其内容进行限定。
本发明提供的壳聚糖酶基因CsnA的核苷酸序列如SEQ ID NO:1所示,其是通过对来源于天蓝色链霉菌的壳聚糖酶的序列根据毕赤酵母密码子的偏好性进行综合优化得到。本发明壳聚糖酶CsnA的氨基酸序列如SEQ ID NO:2所示,为真菌壳聚糖酶,其酶解产物特征与Ⅲ型壳聚糖酶底物识别特性相符。本专利不仅丰富了壳聚糖酶的种类和来源途径,且其自身具有较高的酶活性,在较宽的温度和pH范围内均表现出良好的稳定性,具有良好的应用前景和产业价值。
SEQID NO:1(密码子优化前序列)
GCGACGGGACTCGACGACCCGGCGAAGAAGGAGATCGCCATGCAACTGGTGTCGAGCGCCGAGAACTCCTCGCTCGACTGGAAGGCCCAGTACCGGTACATCGAGGACATCGGTGACGGTCGCGGCTACACCGCGGGCATCATCGGCTTCTGTTCCGGCACCGGCGACATGCTCGACCTGGTGGAGCTGTACGGCGAGCGCAGCCCCGGGAACGTCCTCGCGCCCTATCTGCCGGCGCTGCGCCGGGTGGACGGCTCCGACTCGCACGAGGGCCTCGACCCCGGCTTCCCGGACGACTGGCGCCGGGCCGCCGACCAGGACCCGCAGTTCCGCCGGGCCCAGGACGACGAGCGGGACCGCGTGTACTTCGACCCGGCCGTACGGCGCGGCAAGGAGGACGGGCTGCGGACGCTGGGGCAGTTCGCGTACTACGACGCGATGGTGATGCACGGCGACGGCGGCGGCCTCGGCTTCGGCAGTATCCGCGAGCGCGCCCTCGGCCGGGCCCGCCCGCCGGCCCAGGGCGGTGACGAGGTCGCCTACCTGCACGCCTTCCTCGACGAGCGGGTGTGGGCCATGAAGCAGGAGCAGGCGCACAGCGACACCAGCCGGGTCGACACGGCGCAGCGCGTCTTCCTGAACGAGGGCAACCTGGACCTCGAGCCGCCGCTGGACTGGCACGTGTACGGGGACGCCTACCACATCGGC
根据毕赤酵母密码子偏好性进行密码子优化后序列
GCCACTGGTTTGGATGATCCAGCTAAGAAGGAAATTGCTATGCAATTGGTTTCTTCTGCTGAAAACTCTTCTTTGGATTGGAAGGCTCAATACAGATATATTGAAGATATTGGTGACGGTAGAGGTTACACTGCTGGTATTATTGGTTTCTGTTCTGGTACTGGAGATATGCTGGATTTGGTTGAATTGTACGGTGAAAGATCTCCAGGTAACGTTTTGGCTCCATACTTGCCAGCTTTGAGAAGAGTTGATGGTTCTGATTCTCATGAAGGTTTGGATCCAGGTTTTCCAGATGATTGGAGAAGAGCTGCTGATCAAGATCCTCAATTCAGAAGAGCCCAAGATGATGAAAGAGATAGAGTTTACTTTGATCCAGCTGTTAGAAGAGGAAAGGAAGATGGTTTGAGAACTTTGGGTCAATTTGCTTACTACGATGCTATGGTTATGCATGGTGACGGTGGTGGTTTGGGTTTCGGTTCTATTAGAGAAAGAGCCTTGGGTAGAGCTAGACCTCCAGCTCAAGGTGGAGATGAAGTTGCTTACTTGCATGCTTTCTTGGATGAAAGAGTTTGGGCTATGAAGCAAGAACAAGCTCATTCTGATACTTCTAGAGTTGATACTGCTCAAAGAGTTTTCTTGAACGAAGGTAACTTGGATTTGGAACCACCATTGGATTGGCATGTTTACGGAGATGCTTACCATATTGGT
SEQ ID NO:2 (CsnA氨基酸序列)
Ala Thr Gly Leu Asp Asp Pro Ala Lys Lys Glu Ile Ala Met Gln Leu ValSer Ser Ala Glu Asn Ser Ser Leu Asp Trp Lys Ala Gln Tyr Arg Tyr Ile Glu AspIle Gly Asp Gly Arg Gly Tyr Thr Ala Gly Ile Ile Gly Phe Cys Ser Gly Thr GlyAsp Met Leu Asp Leu Val Glu Leu Tyr Gly Glu Arg Ser Pro Gly Asn Val Leu AlaPro Tyr Leu Pro Ala Leu Arg Arg Val Asp Gly Ser Asp Ser His Glu Gly Leu AspPro Gly Phe Pro Asp Asp Trp Arg Arg Ala Ala Asp Gln Asp Pro Gln Phe Arg ArgAla Gln Asp Asp Glu Arg Asp Arg Val Tyr Phe Asp Pro Ala Val Arg Arg Gly LysGlu Asp Gly Leu Arg Thr Leu Gly Gln Phe Ala Tyr Tyr Asp Ala Met Val Met HisGly Asp Gly Gly Gly Leu Gly Phe Gly Ser Ile Arg Glu Arg Ala Leu Gly Arg AlaArg Pro Pro Ala Gln Gly Gly Asp Glu Val Ala Tyr Leu His Ala Phe Leu Asp GluArg Val Trp Ala Met Lys Gln Glu Gln Ala His Ser Asp Thr Ser Arg Val Asp ThrAla Gln Arg Val Phe Leu Asn Glu Gly Asn Leu Asp Leu Glu Pro Pro Leu Asp TrpHis Val Tyr Gly Asp Ala Tyr His Ile Gly
实例1:壳聚糖酶CsnA基因密码子优化及表达载体制备
获得天蓝色链霉菌CsnA(SCO0677,GenBank:NC_003888.3)基因序列,根据相关文献去除信号肽,保留酶的成熟区,构建pPIC9K载体质粒(小写为载体序列,大写为CsnA成熟区序列)。
pPIC9K质粒载体的构建方法:
tatctctcgagaaaagagaggctgaagctGCCACTGGTTTGGATGATCCAGCTAAGAAGGAAATTGCTATGCAATTGGTTTCTTCTGCTGAAAACTCTTCTTTGGATTGGAAGGCTCAATACAGATATATTGAAGATATTGGTGACGGTAGAGGTTACACTGCTGGTATTATTGGTTTCTGTTCTGGTACTGGAGATATGCTGGATTTGGTTGAATTGTACGGTGAAAGATCTCCAGGTAACGTTTTGGCTCCATACTTGCCAGCTTTGAGAAGAGTTGATGGTTCTGATTCTCATGAAGGTTTGGATCCAGGTTTTCCAGATGATTGGAGAAGAGCTGCTGATCAAGATCCTCAATTCAGAAGAGCCCAAGATGATGAAAGAGATAGAGTTTACTTTGATCCAGCTGTTAGAAGAGGAAAGGAAGATGGTTTGAGAACTTTGGGTCAATTTGCTTACTACGATGCTATGGTTATGCATGGTGACGGTGGTGGTTTGGGTTTCGGTTCTATTAGAGAAAGAGCCTTGGGTAGAGCTAGACCTCCAGCTCAAGGTGGAGATGAAGTTGCTTACTTGCATGCTTTCTTGGATGAAAGAGTTTGGGCTATGAAGCAAGAACAAGCTCATTCTGATACTTCTAGAGTTGATACTGCTCAAAGAGTTTTCTTGAACGAAGGTAACTTGGATTTGGAACCACCATTGGATTGGCATGTTTACGGAGATGCTTACCATATTGGTCATCATCATCATCATCATTAAttcgccttagacatgactgttcc
实例2:毕赤酵母转化
毕赤酵母转化使用氯化锂法:(1)挑取毕赤酵母GS115于20mL YPD培养基中,30℃震荡培养过夜,次日以1%接种量接种至50 mL YPD培养基中,30℃振荡培养至OD600=0.8~1.0。(2)室温下5000 rpm收集细胞,以25ml灭菌去离子水洗涤一次,室温下5000rpm离心10min。(3)重悬细胞于1mL浓度为 100 mmol/L的氯化锂溶液中,转移至1.5mL离心管。(4)室温下12000 rpm离心1min,弃上清,重悬于400μL浓度为100mmol/L的氯化锂溶液中,按50μL分装,制得感受态细胞,立即进行转化。
转化过程:(1)将质粒pPIC9K-CsnA经SacI内切酶线性化后,胶回收纯化。(2)煮沸鲑鱼精DNA 5min,迅速置于冰上。(3)离心感受态细胞,弃上清,加入240μL PEG3350、1mol/L氯化锂36 μL和2mg/mL鲑鱼精DNA,50 μL胶回收纯化质粒,剧烈旋涡震荡混匀后置于30℃孵育30 min。(4)42℃热休克25 min,室温下8000 rpm,离心10 min。(5)pPICZαA-CsnA质粒转化加入1mL 的YPD培养基,30℃震荡培养2h,以产生博来霉素抗性,培养结束后涂布于含100μg/ml的YPD平板中,pPIC9K-CsnA质粒转化用1ml灭菌去离子水悬浮后涂布于MD平板,30℃培养2~4d。
实例3:毕赤酵母重组子表型筛选
pPIC9K-CsnA筛选:将正常生长于MD平板上的单菌落用消毒牙签蘸取后分别点接于MM与MD平板中,先点MM平板,于30℃培养2~4 d,若在两个平板都正常生长,表型即为Mut+His+(如图1)。
实例4:毕赤酵母重组子PCR鉴定
将pPIC9K-CsnA重组菌置于20mL的 YPD培养基中,30℃震荡培养过夜,提取基因组后,利用下表引物CsnA-F,CsnA-R引物进行PCR扩增鉴定,PCR反应程序为94℃预变性5 min,94℃变性30s,55℃退火45 s,72℃延伸45 s,72 ℃补充延伸10 min,PCR产物经1%琼脂糖凝胶电泳检测,得到708 bp的CsnA基因片段(如图2)。
表1. CsnA基因的引物信息
引物名称 | 引物序列 |
CsnA-F | GCCACTGGTTTGGATGATCCA |
CsnA-R | ACCAATATGGTAAGCATCTCCGT |
实例5:毕赤酵母重组子多拷贝筛选
将PCR鉴定正确的阳性菌于YPD培养基划线纯化,用消毒牙签蘸取单菌落分别点接于含1mg/ml,2mg/ml,3mg/ml,4mg/ml抗生素的YPD平板上,pPIC9K-CsnA使用遗传霉素G418,选取各个浓度平板上都可以正常生长的菌株,于YPD平板划线纯化后,可用于表达(如图3)。
实例6:壳聚糖酶诱导表达
挑取纯化好的单菌落于25mL的 BMGY培养基中,30℃,250 rpm振荡培养至OD600为2~6(约16~18h),室温5000 rpm离心收集菌体,弃上清,用一定量BMMY培养基重悬菌体,接种于100mL的 BMMY培养基中,使初始OD600为1~2,30 ℃,250 rpm振荡诱导表达168 h,每24 h添加100%甲醇使培养基中甲醇终浓度为0.5%,168 h后4℃,5000 rpm离心,上清则为粗酶液。经SDS-PAGE电泳检测,可见壳聚糖酶蛋白条带,大小为26.2kDa(如图4)。
实例7:壳聚糖酶酶活测定
在离心管中加入1%壳聚糖350 μL 和50 μL粗酶液,50℃水浴10 min,加入600 μLDNS试剂终止反应,沸水浴10 min,冷却后,室温12000 rpm离心5min,于紫外分光光度计测定OD540,以氨基葡萄糖作为参照,酶活定义:每分钟生成1 μmol氨基葡萄糖为一个酶活单位,毕赤酵母高拷贝菌株在适宜的发酵条件下,酶活力可达10.3 U/mL。利用硫酸铵盐析提取酶蛋白,当沉淀饱和度为75%时,蛋白溶液酶活最高达到 78.5 U/mL,此时溶液的比酶活力为545.1 U/mg(根据溶液中的蛋白含量计算),纯化倍数为1.85(如图5和图6所示)。
实例8:壳聚糖酶的最适反应温度和温度稳定性。
利用Q-Sepharose Fast Flow column离子交换柱层析纯化壳聚糖酶,将纯化的酶液分别于等体积柠檬酸缓冲液(pH 4.0, 5.0, 6.0,7.0)和甘氨酸-氢氧化钠缓冲液(pH8.0,9.0)混合,测定不同pH值下的酶活力。分别设定不同温度(20,30,40,50,60,70和80℃),测定不同酶活力。计算相对酶活力,确定最适反应pH值和温度。
壳聚糖酶的最适反应温度和温度稳定性如图 7所示,反应温度在 20℃~70℃范围内,酶活力变化较大;在50℃时,该壳聚糖酶的相对酶活力最高 99% ;而大于50℃,酶活力下降。因此,该壳聚糖酶的最适反应温度为 50℃ 。该酶在 35℃~50℃范围内稳定性较好,其中50℃保存 60 min 时相对酶活力仍残留85%以上,但当温度上升到60℃,酶活力显著下降。此条件下保温30 min和60 min 时,酶活力分别为57%和50%。因此,该壳聚糖酶在温度为35℃~60℃具有一定的稳定性。
实例9:壳聚糖酶的最适反应pH值和酸碱稳定性。
如图8所示,壳聚糖酶的最适作用pH值呈现先升高后降低的趋势,在pH 值为5.5和6.0时,该壳聚糖酶的相对酶活力最高,达97%。因此该壳聚糖酶的最适反应pH值为5.5-6.0。壳聚糖酶在不同pH值条件下保温60 min 后,酶活力都有所下降。如图8所示,在 pH 4.0-8.0 时,相对比较稳定;而当pH 值<4.0或>8.0时,酶活力显著下降。因此,认为该酶在pH4.0-8.0范围内,具有一定的稳定性。
实例10:壳聚糖酶的产物结构特征。
为获得壳聚糖酶对底物的位点识别特性及产物的结构特征,进一步使用1H NMR及13C NMR对水解产物进行鉴定,结果见图9。由图 9可知:水解产物的还原末端主要由氨基葡萄糖组成(图9(a)),而非还原末端则同时含有氨基葡萄糖及N乙酰氨基葡萄糖(图9(b))。上述结果说明该酶可同时水解糖苷键GlcN-GlcN及GlcN-Glc NAc,与Ⅲ型壳聚糖酶底物识别特性相符。通过薄层层析分析发现,壳聚糖酶降解壳聚糖2h的产物主要为二糖、三糖和少量四糖,结果见图10。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内所作的任何修改、等同替换、改进等,均应包含在本发明的包含范围之内。
序列表
<110> 南宁新科健生物技术有限公司
<120> 一种新型壳聚糖酶及其制备方法
<141> 2021-08-20
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 708
<212> DNA
<213> 天蓝色链霉菌(Streptomyces coeruleus)
<400> 1
gccactggtt tggatgatcc agctaagaag gaaattgcta tgcaattggt ttcttctgct 60
gaaaactctt ctttggattg gaaggctcaa tacagatata ttgaagatat tggtgacggt 120
agaggttaca ctgctggtat tattggtttc tgttctggta ctggagatat gctggatttg 180
gttgaattgt acggtgaaag atctccaggt aacgttttgg ctccatactt gccagctttg 240
agaagagttg atggttctga ttctcatgaa ggtttggatc caggttttcc agatgattgg 300
agaagagctg ctgatcaaga tcctcaattc agaagagccc aagatgatga aagagataga 360
gtttactttg atccagctgt tagaagagga aaggaagatg gtttgagaac tttgggtcaa 420
tttgcttact acgatgctat ggttatgcat ggtgacggtg gtggtttggg tttcggttct 480
attagagaaa gagccttggg tagagctaga cctccagctc aaggtggaga tgaagttgct 540
tacttgcatg ctttcttgga tgaaagagtt tgggctatga agcaagaaca agctcattct 600
gatacttcta gagttgatac tgctcaaaga gttttcttga acgaaggtaa cttggatttg 660
gaaccaccat tggattggca tgtttacgga gatgcttacc atattggt 708
<210> 2
<211> 236
<212> PRT
<213> 天蓝色链霉菌(Streptomyces coeruleus)
<400> 2
Ala Thr Gly Leu Asp Asp Pro Ala Lys Lys Glu Ile Ala Met Gln Leu
1 5 10 15
Val Ser Ser Ala Glu Asn Ser Ser Leu Asp Trp Lys Ala Gln Tyr Arg
20 25 30
Tyr Ile Glu Asp Ile Gly Asp Gly Arg Gly Tyr Thr Ala Gly Ile Ile
35 40 45
Gly Phe Cys Ser Gly Thr Gly Asp Met Leu Asp Leu Val Glu Leu Tyr
50 55 60
Gly Glu Arg Ser Pro Gly Asn Val Leu Ala Pro Tyr Leu Pro Ala Leu
65 70 75 80
Arg Arg Val Asp Gly Ser Asp Ser His Glu Gly Leu Asp Pro Gly Phe
85 90 95
Pro Asp Asp Trp Arg Arg Ala Ala Asp Gln Asp Pro Gln Phe Arg Arg
100 105 110
Ala Gln Asp Asp Glu Arg Asp Arg Val Tyr Phe Asp Pro Ala Val Arg
115 120 125
Arg Gly Lys Glu Asp Gly Leu Arg Thr Leu Gly Gln Phe Ala Tyr Tyr
130 135 140
Asp Ala Met Val Met His Gly Asp Gly Gly Gly Leu Gly Phe Gly Ser
145 150 155 160
Ile Arg Glu Arg Ala Leu Gly Arg Ala Arg Pro Pro Ala Gln Gly Gly
165 170 175
Asp Glu Val Ala Tyr Leu His Ala Phe Leu Asp Glu Arg Val Trp Ala
180 185 190
Met Lys Gln Glu Gln Ala His Ser Asp Thr Ser Arg Val Asp Thr Ala
195 200 205
Gln Arg Val Phe Leu Asn Glu Gly Asn Leu Asp Leu Glu Pro Pro Leu
210 215 220
Asp Trp His Val Tyr Gly Asp Ala Tyr His Ile Gly
225 230 235
<210> 3
<211> 21
<212> DNA
<213> 引物(Primer)
<400> 3
gccactggtt tggatgatcc a 21
<210> 4
<211> 23
<212> DNA
<213> 引物(Primer)
<400> 4
accaatatgg taagcatctc cgt 23
Claims (10)
1.一种新型壳聚糖酶CsnA,其特征在于,其核苷酸序列如SEQ ID NO:1所示。
2.如权利要求1所述的新型壳聚糖酶CsnA,其特征在于,其氨基酸序列如SEQ ID NO:2所示。
3.如权利要求1或2所述的新型壳聚糖酶CsnA在降解壳聚糖/制备壳聚糖中的应用;在制备降解壳聚糖/制备壳聚糖的酶制剂的应用。
4.一种重组表达载体,其特征在于,包括权利要求1所述新型壳聚糖酶CsnA。
5.如权利要求1所述新型壳聚糖酶CsnA的制备方法,其特征在于,
提供壳聚糖酶CsnA基因、构建载体质粒和毕赤酵母转化;
对所述载体质粒进行转化;
对所述壳聚糖酶CsnA基因进行扩增;
其中,所述壳聚糖酶CsnA的核苷酸序列如SEQ ID NO:1所示。
6.根据权利要求5所述新型壳聚糖酶CsnA的制备方法,其特征在于,将所述壳聚糖酶CsnA基因进行扩增的步骤中,用于扩增的引物包括正向引物和反向引物,所述正向引物的核苷酸序列如SEQ ID NO:3所示,所述反向引物的核苷酸序列如SEQ ID NO:4所示。
7.根据权利要求5所述新型壳聚糖酶CsnA的制备方法,其特征在于,所述载体为毕赤酵母表达载体。
8.根据权利要求5所述新型壳聚糖酶CsnA的制备方法,其特征在于,所述表达菌株为毕赤酵
母表达菌株。
9.一种酶制剂,其特征在于:包含有权利要求1所述的新型壳聚糖酶CsnA。
10.如权利要求9所述的酶制剂在降解壳聚糖/制备壳寡糖中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110960970.6A CN113430188A (zh) | 2021-08-20 | 2021-08-20 | 一种新型壳聚糖酶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110960970.6A CN113430188A (zh) | 2021-08-20 | 2021-08-20 | 一种新型壳聚糖酶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113430188A true CN113430188A (zh) | 2021-09-24 |
Family
ID=77797749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110960970.6A Pending CN113430188A (zh) | 2021-08-20 | 2021-08-20 | 一种新型壳聚糖酶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113430188A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113817758A (zh) * | 2021-10-11 | 2021-12-21 | 湖南省植物保护研究所 | 编码贝莱斯芽孢杆菌的壳聚糖酶基因、壳聚糖酶及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110819611A (zh) * | 2020-01-10 | 2020-02-21 | 中国农业科学院生物技术研究所 | 壳聚糖酶突变体及其编码基因和应用 |
-
2021
- 2021-08-20 CN CN202110960970.6A patent/CN113430188A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110819611A (zh) * | 2020-01-10 | 2020-02-21 | 中国农业科学院生物技术研究所 | 壳聚糖酶突变体及其编码基因和应用 |
Non-Patent Citations (1)
Title |
---|
MARIANA GABRIELA GHINET ET AL: "WP_011027289.1", 《NCBI》, pages 1 - 17 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113817758A (zh) * | 2021-10-11 | 2021-12-21 | 湖南省植物保护研究所 | 编码贝莱斯芽孢杆菌的壳聚糖酶基因、壳聚糖酶及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106884025B (zh) | 一种酶法水解定向制备褐藻胶寡糖的方法 | |
CN112646794B (zh) | 低温活性提高的外切菊粉酶突变体MutY119V | |
CN111041017B (zh) | 一种壳聚糖酶突变体及其应用 | |
CN109385413B (zh) | 葡萄糖淀粉酶TlGA1931及其基因和应用 | |
JP7241368B2 (ja) | アオサ多糖リアーゼおよびそのコード遺伝子と応用 | |
CN110066777B (zh) | 一种内切菊粉酶及其在生产低聚果糖中的应用 | |
CN113862241B (zh) | 一种壳聚糖酶Csncv及其突变体CsnB和应用 | |
CN108102936B (zh) | 乳酸克鲁维酵母突变株及其糖苷酶和应用 | |
CN108587926B (zh) | 黑曲霉、其α-L-鼠李糖苷酶制备方法及质粒载体及重组菌 | |
CN107603994B (zh) | 一种κ-卡拉胶酶及其基因和应用 | |
CN111996205A (zh) | 几丁质酶基因、几丁质酶及其制备方法和应用 | |
CN113430188A (zh) | 一种新型壳聚糖酶及其制备方法 | |
CN109295031B (zh) | 一种抗真菌蛋白β-1,3-葡聚糖酶和含有该基因的工程菌及其应用 | |
WO2016090525A1 (zh) | 真菌来源的高温酸性β-葡萄糖苷酶及其编码基因和应用 | |
CN110272884B (zh) | 一种用于几丁寡糖制备的几丁质酶及其基因 | |
CN109593744B (zh) | 一种琼胶酶及其制备方法 | |
CN113832129B (zh) | 一种壳聚糖酶突变体CsnBa1及其应用 | |
US10655117B2 (en) | Pullulanase and use thereof | |
CN110904064A (zh) | 一种果糖基转移酶的基因序列及其制备方法和应用 | |
CN108611339B (zh) | 葡萄糖淀粉酶TlGa15及其基因和应用 | |
CN113717915B (zh) | 表面表达acc脱氨酶的水稻黄单胞菌及其构建方法与应用 | |
CN115141841A (zh) | 一种毕赤酵母突变菌株及其在海藻酸裂解酶生产中的应用 | |
CN110257361B (zh) | 一种褐藻胶裂解酶及其基因和应用 | |
CN113817758A (zh) | 编码贝莱斯芽孢杆菌的壳聚糖酶基因、壳聚糖酶及其制备方法和应用 | |
WO2021103123A1 (zh) | 一种葡萄糖氧化酶m5god及其编码基因和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |